Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010
نویسندگان
چکیده
BACKGROUND In the UK, a man's lifetime risk of being diagnosed with prostate cancer is 1 in 8. We calculated both the lifetime risk of being diagnosed with and dying from prostate cancer by major ethnic group. METHODS Public Health England provided prostate cancer incidence and mortality data for England (2008-2010) by major ethnic group. Ethnicity and mortality data were incomplete, requiring various assumptions and adjustments before lifetime risk was calculated using DevCan (percent, range). RESULTS The lifetime risk of being diagnosed with prostate cancer is approximately 1 in 8 (13.3 %, 13.2-15.0 %) for White men, 1 in 4 (29.3 %, 23.5-37.2 %) for Black men, and 1 in 13 (7.9 %, 6.3-10.5 %) for Asian men, whereas that of dying from prostate cancer is approximately 1 in 24 (4.2 %, 4.2-4.7 %) for White men, 1 in 12 (8.7 %, 7.6-10.6 %) for Black men, and 1 in 44 (2.3 %, 1.9-3.0 %) for Asian men. CONCLUSIONS In England, Black men are at twice the risk of being diagnosed with, and dying from, prostate cancer compared to White men. This is an important message to communicate to Black men. White, Black, and Asian men with a prostate cancer diagnosis are all as likely to die from the disease, independent of their ethnicity. Nonetheless, proportionally more Black men are dying from prostate cancer in England.
منابع مشابه
Bone scintigraphy in staging of newly diagnosed prostate cancer in regard of different risk groups
Objective(s): Prostate cancer (PC) is the most common cancer in men over 50 years of age. Bone scintigraphy is still performed in many institutions at the time of primary diagnosis. We aimed to evaluate the role of bone scan in the primary staging of PC in regard of different risk groups. Methods: A retrospective analysis of bone scans i...
متن کاملDoes the benefit justify the risk?
The past two decades have witnessed a dramatic increase in the number of men who have been diagnosed with prostate cancer. Since the introduction of prostate-specific antigen (PSA) testing, approximately 90 000 additional men have been diagnosed annually and large numbers of these men have received treatments, such as radical prostatectomy, radiation therapy, or androgen deprivation therapy (AD...
متن کاملProstate Cancer Screening in Middle-Aged and Older American Men: Combined Effects of Ethnicity and Years of Schooling
Background: Prostate cancer screening is more commonly utilized by highly educated people. As shown by marginalization-related diminished returns (MDRs), the effects of socioeconomic status (SES) such as education on the health outcomes are considerably smaller for ethnic minorities than for Whites. The role of MDRs as a source of ethnic health disparities is, however, still un...
متن کاملAmerican Family Physician
A bout 218,890 new prostate cancer diagnoses were expected in the United States during 2007, with 27,050 men dying of the disease. Men have a 17 percent lifetime risk of prostate cancer, but only a 3 percent risk of dying from the disease. Black men have the highest incidence of prostate cancer in the world. The age-adjusted death rate from prostate cancer is 64.4 per 100,000 for black men comp...
متن کاملبررسی نقش ژن CYP1B1 در سرطان پروستات در دو جمعیت ایرانی و هندی
Prostate cancer (PCa) is the most common non-skin cancer and the second leading cause of cancer death among men in the world. Growth, maintenance and the expression of genes involved in the production of steroids, may alter the susceptibility of prostate cancer. One such gene, CYP1B1 (cytochrome P450, family 1, subfamily B, polypeptide 1) is involved in the activation of many carcinogens and i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 13 شماره
صفحات -
تاریخ انتشار 2015